The utility of platelet activation biomarkers in thrombotic microangiopathies
Primary thrombotic microangiopathies (TMAs) are observed in thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), while secondary TMAs have a wide range of etiologies. Early diagnosis and treatment of TMA are critical for patient well-being; however, distinguishing TTP from...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Taylor & Francis Group
2022-05-01
|
| Edice: | Platelets |
| Témata: | |
| On-line přístup: | http://dx.doi.org/10.1080/09537104.2022.2026912 |